China’s new directives on nutraceuticals and Hong Kong experience
Refereed conference paper presented and published in conference proceedings

香港中文大學研究人員
替代計量分析
.

其它資訊
摘要Nutraceuticals could be interpreted as nutritional supplements any food substance that is good for health from dairy products to protein or fruit concentrates. Nutraceuticals could be more specific with clear target groups and special claims. China is moving towards that direction. Its State FDA since 2015 has issued a series of guideline for the development of nutritional supplements with special medicinal purposes and contents. Three areas are given immediate priorities viz. infants, lactating mothers and elderlies. Proper clinical trials are recommended. The Institute of Chinese Medicine at Chinese University of Hong Kong has been seriously developing medicinal supplements since year 2000. It has followed the evidence-based approach: From quality assurance, safety, bioactivity confirmations to proper clinical trials. Classical popular complex herbal formulations have been modified into simple combinations to form effective, medicinal supplement to support allopathic treatment of special conditions. The choice of herbs is guided by the pathological processes involved in particular disease entities. Examples of medicinal supplements developed for cancer and cardiovascular treatment will be given to illustrate the principle and procedures involved.
著者Leung PC
會議名稱30th International Conference on Nutraceuticals and Natural Medicine
會議開始日28.01.2019
會議完結日29.01.2019
會議地點Osaka
會議國家/地區日本
會議論文集題名Journal of Nutrition & Food Sciences
出版年份2019
月份1
卷號9
頁次15 - 15
國際標準期刊號2155-9600
語言英式英語

上次更新時間 2020-27-11 於 01:09